Alvotech Swiss AG

Related records

Trials (20)

• A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants
• Auto-injector Real Life Handling in Patients
• AVT03 With Prolia in Healthy Male Subjects
• AVT03 With Xgeva in Healthy Male Subjects
• Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE)
• Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema
• Clinical Study to Evaluate the Handling and Safety of AVT06 PFS in Subjects With Chorioretinal Vascular Disease
• Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers
• Comparative, Multicenter Study in Subjects with Rheumatoid Arthritis, ALVOFLEX
• Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis
• Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis
• Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND
• Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma
• Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis
• Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)
• Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)
• Pilot Study of AVT16 in Healthy Adult Subjects
• PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)
• Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio
• Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio